When are we going to take modifiable risk factors more seriously in multiple sclerosis?

Affiliations

¹ National MS Society, New York, NY, USA.
² Faculty of Brain Sciences, Institute of Neurology, University College London, London, UK.

Editorial

Tim Coetzee et al. Mult Scler. 2017 Apr.

. 2017 Apr;23(4):494-495.

doi: 10.1177/1352458517694433.

¹ National MS Society, New York, NY, USA.
² Faculty of Brain Sciences, Institute of Neurology, University College London, London, UK.

No abstract available

Comment on

A systematic review of modifiable risk factors in the progression of multiple sclerosis.
Hempel S, Graham GD, Fu N, Estrada E, Chen AY, Miake-Lye I, Miles JN, Shanman R, Shekelle PG, Beroes JM, Wallin MT. Hempel S, et al. Mult Scler. 2017 Apr;23(4):525-533. doi: 10.1177/1352458517690270. Epub 2017 Feb 2. Mult Scler. 2017. PMID: 28151053
A systematic review of the effects of modifiable risk factor interventions on the progression of multiple sclerosis.
Hempel S, Graham GD, Fu N, Estrada E, Chen AY, Miake-Lye I, Miles JN, Shanman R, Shekelle PG, Beroes JM, Wallin MT. Hempel S, et al. Mult Scler. 2017 Apr;23(4):513-524. doi: 10.1177/1352458517690271. Epub 2017 Feb 2. Mult Scler. 2017. PMID: 28151074